ResMed Keeps Bull on Margin, Demand Prospects -- Market Talk

Dow Jones

2025/08/05

0030 GMT - ResMed keeps its bull at Macquarie on what the investment banks' analysts see at positive medium-term demand catalysts and the likelihood of sustained near-term margin expansion. Maintaining an outperform rating on the stock, the Macquarie analysts write in a note that the breathing-tech manufacturer's 4Q margin was stronger than they had anticipated. They attribute the beat to operational efficiencies, including in procurement, manufacturing, and logistics. With capital returns accelerating and awareness of sleep apnea rising, Macquarie lifts its target price on the stock by 5.9% to A$48.60. Shares are up 4.6% at A$44.88. (stuart.condie@wsj.com)

(END) Dow Jones Newswires

August 04, 2025 20:30 ET (00:30 GMT)

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2557235696"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2557235696\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2557235696?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-05 08:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2557235696","market":"fut","top_or_hot":-1,"title":"ResMed Keeps Bull on Margin, Demand Prospects -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0030 GMT - <a href=\"https://laohu8.com/S/RMD\">ResMed</a> keeps its bull at <a href=\"https://laohu8.com/S/MQG.AU\">Macquarie</a> on what the investment banks' analysts see at positive medium-term demand catalysts and the likelihood of sustained near-term margin expansion. Maintaining an outperform rating on the stock, the Macquarie analysts write in a note that the breathing-tech manufacturer's 4Q margin was stronger than they had anticipated. They attribute the beat to operational efficiencies, including in procurement, manufacturing, and logistics. With capital returns accelerating and awareness of sleep apnea rising, Macquarie lifts its target price on the stock by 5.9% to A$48.60. Shares are up 4.6% at A$44.88. (stuart.condie@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  August 04, 2025 20:30 ET (00:30 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ResMed Keeps Bull on Margin, Demand Prospects -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nResMed Keeps Bull on Margin, Demand Prospects -- Market Talk\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-08-05 08:30</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0030 GMT - <a href=\"https://laohu8.com/S/RMD\">ResMed</a> keeps its bull at <a href=\"https://laohu8.com/S/MQG.AU\">Macquarie</a> on what the investment banks' analysts see at positive medium-term demand catalysts and the likelihood of sustained near-term margin expansion. Maintaining an outperform rating on the stock, the Macquarie analysts write in a note that the breathing-tech manufacturer's 4Q margin was stronger than they had anticipated. They attribute the beat to operational efficiencies, including in procurement, manufacturing, and logistics. With capital returns accelerating and awareness of sleep apnea rising, Macquarie lifts its target price on the stock by 5.9% to A$48.60. Shares are up 4.6% at A$44.88. (stuart.condie@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  August 04, 2025 20:30 ET (00:30 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RMD.AU","symbol_name":"Resmed DRC","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2557235696","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2557235696","pubTimestamp":1754353800,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0030 GMT - ResMed keeps its bull at Macquarie on what the investment banks' analysts see at positive medium-term demand catalysts and the likelihood of sustained near-term margin expansion. Maintaining an outperform rating on the stock, the Macquarie analysts write in a note that the breathing-tech manufacturer's 4Q margin was stronger than they had anticipated. They attribute the beat to operational efficiencies, including in procurement, manufacturing, and logistics. With capital returns accelerating and awareness of sleep apnea rising, Macquarie lifts its target price on the stock by 5.9% to A$48.60. Shares are up 4.6% at A$44.88. ","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"RMD.AU":"Resmed DRC","RMD":"瑞思迈"},"translate_title":"瑞思迈继续看好利润率和需求前景——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RMD.AU":0.9,"RMD":1},"content_text":"0030 GMT - ResMed keeps its bull at Macquarie on what the investment banks' analysts see at positive medium-term demand catalysts and the likelihood of sustained near-term margin expansion. Maintaining an outperform rating on the stock, the Macquarie analysts write in a note that the breathing-tech manufacturer's 4Q margin was stronger than they had anticipated. They attribute the beat to operational efficiencies, including in procurement, manufacturing, and logistics. With capital returns accelerating and awareness of sleep apnea rising, Macquarie lifts its target price on the stock by 5.9% to A$48.60. Shares are up 4.6% at A$44.88. (stuart.condie@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 04, 2025 20:30 ET (00:30 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}